Illumina, Inc.
- Last sale
- Nov 12, 2026 · -1.56%
- Market cap
- $31.68B
- 151.2M shares
- Filings
- 1,085
Q3 2026−0.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derived+31.3% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+25.8% FY25 yoy
- $31.68B
- 35.4×
- 7.0×
- 10.1×
- 3.34%
- —
Twelve months to Sep 27, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-28 | $4,343,000,000 | reported | |
| FY 2024 | 2024-12-29 | $4,372,000,000 | reported | |
| FY 2023 | 2023-12-31 | $4,504,000,000 | reported | |
| FY 2022 | 2023-01-01 | $4,584,000,000 | reported | |
| FY 2021 | 2022-01-02 | $4,526,000,000 | reported | |
| FY 2020 | 2021-01-03 | $3,239,000,000 | reported | |
| FY 2019 | 2019-12-29 | $3,543,000,000 | reported | |
| FY 2018 | 2018-12-30 | $3,333,000,000 | reported | |
| FY 2017 | 2017-12-31 | $2,752,000,000 | reported | |
| FY 2016 | 2017-01-01 | $2,398,000,000 | reported | |
| FY 2015 | 2016-01-03 | $2,220,000,000 | reported | |
| FY 2014 | 2014-12-28 | $1,861,358,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $742.00M | $742.00M | — | 152.90M sh | −3.5% | 79.7% |
| FY2024 | — | $116.00M | $116.00M | — | 158.40M sh | −0.3% | 16.4% |
| FY2023 | — | $0.00 | $0.00 | — | 158.90M sh | +0.6% | 0.0% |
| FY2022 | — | $0.00 | $0.00 | — | 158.00M sh | +0.6% | 0.0% |
| FY2021 | — | $0.00 | $0.00 | — | 157.00M sh | +7.6% | 0.0% |
Segments
LineFY2025ShareChange
Core Illumina$4.34B100%+0.3%
Sequencing$3.99B92%−0.2%
Microarray$358.00M8.2%−5.5%
GRAIL$0.00—−100.0%
Helix———
Total$4.34B
Laboratory analytical instruments
Illumina, Inc. is the 3rd largest of the 25 covered companies the SEC files under this code, by revenue. SIC 3826
CompanyRevenueGrowthNet marginMarket cap
AAgilent Technologies, Inc.$6.9B6.7%18.8%$48.8BAVTRAvantor, Inc.$6.6B3.4%8.1%$10.8B
ILMNIllumina, Inc. (this company)$4.3B0.7%19.6%$31.7B
MTDMettler Toledo International Inc$4.0B4.0%21.6%$34.4BBRKRBruker Corp$3.4B2.1%0.3%$9.2BWATWaters Corp$3.2B7.0%20.3%$45.4BRVTYRevvity, Inc.$2.9B3.7%8.4%$17.5BBIOBio-Rad Laboratories, Inc.$2.6B0.7%29.4%$9.6BTXG10x Genomics, Inc.$642.8M5.2%6.8%$7.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Illumina, Inc. · CIK 1110803 · Engraved from SEC EDGAR